Cardiac Magnetic Resonance (CMR) has solidified its position as the “gold standard” for non-invasive assessment of cardiac structure and function. Currently, the field has moved beyond simple volumetric
The landscape of cardiac biomarkers is shifting from simple “damage detection” (like Troponin) to “pathophysiological profiling.” For a clinician focusing on diagnostics, the most relevant newer biomarkers are
Valvular Pulmonary Stenosis (PS) is a form of right ventricular outflow tract obstruction where the pulmonary valve leaflets are thickened, fused, or dysplastic, impeding blood flow from the
Hypoplastic Left Heart Syndrome (HLHS) is a complex and severe congenital heart disease where the left side of the heart is underdeveloped and cannot effectively pump blood to
Concerns about radiation exposure in cardiac CT angiography (CCTA) are valid, but the landscape has shifted dramatically in recent years. The “standard” dose has plummeted thanks to better
The management of Refractory (Stage D) Heart Failure represents the most challenging frontier in cardiology. By definition, these patients remain symptomatic despite optimal medical therapy (OMT) at maximum
Congenital Mitral Stenosis is a rare, complex cardiac anomaly characterized by an anatomical obstruction of the left ventricular inflow. Unlike the acquired version often seen in adults with
Aortic dissection is a critical, life-threatening condition where a tear occurs in the inner layer (intima) of the aorta. This allows blood to surge through the tear, creating
Takotsubo Cardiomyopathy (TTC), often called Broken Heart Syndrome or Stress-Induced Cardiomyopathy, is a fascinating clinical entity that mimics an acute myocardial infarction but typically occurs in the absence
The role of an Implantable Cardioverter Defibrillator (ICD) in heart failure is primarily centered on the prevention of Sudden Cardiac Death (SCD) due to ventricular arrhythmias. While heart
